Gastroparesis from GLP-1 Medications in Arkansas
Last Updated: April 1, 2026
Gastroparesis cases linked to GLP-1 medications are being filed by Arkansas residents. Arkansas provides a relatively generous three-year statute of limitations for both personal injury and product liability claims, giving residents more time to pursue Depo-Provera and GLP-1 medication injury cases. The state's two federal judicial districts cover its diverse landscape from the Delta region to the Ozark highlands. Arkansas also recognizes the discovery rule, which can further extend filing deadlines when injuries from pharmaceutical products are not immediately apparent.
Gastroparesis has been linked to GLP-1 medications including Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity. Arkansas residents who developed gastroparesis after using these drugs may qualify for compensation. The product liability statute of limitations in Arkansas is 3 years. Cases are pending in federal MDL, and attorneys handle claims on a contingency fee basis — no cost unless you win.
Gastroparesis and GLP-1 Medications
Gastroparesis, commonly referred to as stomach paralysis, occurs when the muscles of the stomach fail to function properly, preventing food from moving through the digestive tract at a normal pace. For Arkansas residents who developed gastroparesis after using GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity, the condition can be debilitating and life-altering. Symptoms include severe nausea, persistent vomiting, painful abdominal bloating, dangerous weight loss, and the inability to eat normally. In the most severe cases, patients require hospitalization, feeding tubes, or surgical intervention. The condition can become chronic, requiring ongoing medical management and significantly diminishing quality of life.
The manufacturers of these medications — Novo Nordisk (maker of Ozempic, Wegovy, and Rybelsus) and Eli Lilly (maker of Mounjaro and Trulicity) — are accused of failing to adequately warn patients and prescribing physicians about the risk of gastroparesis. Despite internal data and emerging clinical evidence suggesting a causal link, the drug labels did not include sufficient warnings about the severity and potential permanence of this condition.
For Arkansas residents, this means that if you developed gastroparesis while taking a GLP-1 medication, you may have a valid product liability claim. The federal multidistrict litigation (MDL 3094) is consolidating these cases for efficient pretrial proceedings, while preserving each plaintiff's individual right to trial.
Recognizing Gastroparesis from GLP-1 Drugs
If you are a Arkansas resident who used Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity and experienced any of the following symptoms, you may have developed gastroparesis as a result:
Severe nausea and vomiting
Abdominal pain and bloating
Feeling full after small amounts of food
Unintentional weight loss
Acid reflux
Diagnosis
Gastroparesis is typically confirmed through gastric emptying study (ges). If you are experiencing symptoms but have not yet received a formal diagnosis, an attorney can help coordinate appropriate medical evaluation as part of your case. Having documented medical evidence strengthens your claim significantly.
Filing a Gastroparesis Claim in Arkansas
Arkansas residents who developed gastroparesis after using GLP-1 medications have specific legal options and deadlines. The statute of limitations for product liability claims in Arkansas is 3 years, and the personal injury statute of limitations is 3 years.
Importantly, Arkansas recognizes the discovery rule. This means the statute of limitations clock may not start until you knew or reasonably should have known that your gastroparesis was caused by a GLP-1 medication. Given that the scientific understanding of the link between these drugs and gastroparesis has evolved significantly in recent years, many Arkansas residents may still be within their filing window even if their injury occurred some time ago.
Cases may be filed in the Arkansas Circuit Courts at the state level or in federal court through the Eastern District of Arkansas (or other Arkansas federal districts). Most GLP-1 injury cases are being coordinated through the federal MDL for pretrial proceedings.
Arkansas legal landscape: Arkansas follows modified comparative fault with a 49% bar — a plaintiff who is 50% or more at fault cannot recover. The state applies strict liability for product defect claims and does not impose statutory caps on punitive damages in pharmaceutical cases. Residents in Little Rock, Fort Smith, Fayetteville, and Springdale and surrounding areas should consult with an attorney to evaluate their potential gastroparesis claim.
Personal Injury SOL
3 years
Product Liability SOL
3 years
Discovery Rule
Yes
GLP-1 Drugs Linked to Gastroparesis
The following GLP-1 receptor agonist medications have been linked to gastroparesis in ongoing litigation. If you used any of these drugs in Arkansas and developed gastroparesis, you may qualify for a claim:
Ozempic
Semaglutide injection by Novo Nordisk. Prescribed for type 2 diabetes.
Wegovy
Semaglutide injection by Novo Nordisk. Prescribed for weight management.
Mounjaro
Tirzepatide injection by Eli Lilly. Prescribed for type 2 diabetes and weight management.
Rybelsus
Oral semaglutide by Novo Nordisk. Prescribed for type 2 diabetes.
Saxenda
Liraglutide injection by Novo Nordisk. Prescribed for weight management.
Trulicity
Dulaglutide injection by Eli Lilly. Prescribed for type 2 diabetes.
Do You Qualify for a Gastroparesis Claim in Arkansas?
Arkansas residents may be eligible to file a gastroparesis claim if the following criteria apply:
Used a GLP-1 Medication
You were prescribed and used Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity or another GLP-1 receptor agonist medication.
Diagnosed with Gastroparesis
You received a medical diagnosis of gastroparesis through gastric emptying study (ges).
Injury Occurred After Drug Use
Your gastroparesis developed after you began taking the GLP-1 medication, establishing a timeline consistent with causation.
Within Arkansas's Filing Deadline
Your claim falls within Arkansas's product liability statute of limitations (3 years). The discovery rule may extend this deadline. An attorney can evaluate your specific timeline.
Gastroparesis in Arkansas: FAQ
What is gastroparesis and how is it linked to GLP-1 medications in Arkansas?
Stomach paralysis causing severe nausea, vomiting, and inability to digest food normally. GLP-1 medications including Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity have been linked to an increased risk of developing this condition. Arkansas residents who were prescribed these medications and subsequently developed gastroparesis may be eligible to file a lawsuit seeking compensation for their injuries, medical expenses, and other damages.
What are the symptoms of gastroparesis caused by Ozempic or other GLP-1 drugs?
Common symptoms of gastroparesis include severe nausea and vomiting, abdominal pain and bloating, feeling full after small amounts of food, unintentional weight loss, acid reflux. If you experienced these symptoms after taking Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity in Arkansas, you should seek medical attention immediately and consider having your case evaluated for potential legal action.
How is gastroparesis diagnosed for purposes of a GLP-1 lawsuit?
Gastroparesis is typically diagnosed through gastric emptying study (ges). For Arkansas residents filing a GLP-1 injury claim, medical documentation confirming your diagnosis is important for establishing your case. If you have not yet been formally diagnosed but are experiencing symptoms, your attorney can help coordinate appropriate medical evaluation.
What is the statute of limitations for a gastroparesis claim in Arkansas?
In Arkansas, the statute of limitations for product liability claims is 3 years. Arkansas recognizes the discovery rule, meaning the filing deadline may start from when you discovered or should have discovered that your gastroparesis was caused by a GLP-1 medication. Consult with an attorney to determine your exact deadline.
What compensation can I receive for gastroparesis caused by GLP-1 drugs in Arkansas?
Arkansas residents who qualify may recover compensation for medical expenses (including hospitalization, feeding tubes, and ongoing treatment), lost wages, pain and suffering, emotional distress, and diminished quality of life. The amount depends on the severity of your gastroparesis and its impact on your daily life.
Is there any cost to file a gastroparesis claim in Arkansas?
There is no upfront cost. Attorneys handling GLP-1 gastroparesis cases in Arkansas work on a contingency fee basis, meaning they only receive payment if you receive compensation through settlement or trial verdict. NuLegal's initial case review is completely free with no obligation.
Related Resources
Other GLP-1 Injuries in Arkansas
Arkansas Residents: Get Your Free Case Review
If you developed gastroparesis after using Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity, time may be limited. Arkansas's product liability statute of limitations is 3 years. Get a free, no-obligation evaluation today.
Free Case ReviewAdvertisement
Disclosure: NuLegal operates as a legal referral service. Attorney Ashkaan Hassan evaluates claims and refers qualified cases to specialized trial firms, earning a referral fee from the attorney's share of any recovery. Clients never pay out of pocket.